Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation-Reference-Cited by-同舟云学术

Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation

Published:2004 Issue:2 Volume:19 Page:66-70
ISSN:0733-2459
Container-title:Journal of Clinical Apheresis
language:en
Short-container-title:J. Clin. Apheresis

Author:

Lee Je-Jung,Kook Hoon,Park Myong-Suk,Nam Jong-Hee,Choi Bo-Hwa,Song Won-Hyun,Park Kyeong-Soo,Lee Il-Kwon,Chung Ik-Joo,Hwang Tai-Ju,Kim Hyeoung-Joon

Publisher

Wiley

Subject

Hematology,General Medicine

Reference17 articles.

1. Autologous stem cell transplantation for adult acute leukemia

2. Targeting of a B7-1 (CD80) immunoglobulin G fusion protein to acute myeloid leukemia blasts increases their costimulatory activity for autologous remission T cells

3. Increased angiogenesis and Fas-ligand expression are independent processes in acute myeloid leukemia

4. Dendritic Cells Derived In Vitro From Acute Myelogenous Leukemia Cells Stimulate Autologous, Antileukemic T-Cell Responses

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapies of acute myeloid leukemia: Rationale, clinical evidence and perspective;Biomedicine & Pharmacotherapy;2024-02

2. STATs signaling pathways in dendritic cells: As potential therapeutic targets?;International Reviews of Immunology;2023-10-27

3. Generation of Leukaemia-Derived Dendritic Cells (DCleu) to Improve Anti-Leukaemic Activity in AML: Selection of the Most Efficient Response Modifier Combinations;International Journal of Molecular Sciences;2022-07-28

4. Dendritic cell-based cancer immunotherapy in the era of immune checkpoint inhibitors: From bench to bedside;Life Sciences;2022-05

5. Research progress on dendritic cell vaccines in cancer immunotherapy;Experimental Hematology & Oncology;2022-01-24